Are sugary drinks the sweet poison in your diet? While sugar-sweetened beverages might taste enjoyable and satisfying in the ...

Higher fluoride levels in drinking water may lower children's IQ. Experts urge more research to understand the risks.

Nonopioid vs opioid analgesics after impacted third-molar extractions- ...

Smoking is a significant risk factor for gum disease, tooth decay and oral cancer. Diabetic patients should quit smoking as ...

Learn how AI, blockchain, and IoT are transforming health insurance, improving efficiency, personalizing customer experiences ...

Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model ...

Discover how the Mediterranean diet boosts brain health and cognitive function by balancing gut bacteria, reducing disease ...

Prytime Medical, The REBOA Company™ , proudly announces the first civilian use of its pREBOA-PRO™ catheter in the European Union, following the device's receipt of CE Mark approval.

Real-world data from the largest U.S. Lyme disease registry, MyLymeData, shows current clinical trials for persistent Lyme disease (PLD) systematically exclude most patients who are clinically ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced that the U.S. Food and Drug Administration ...

BIA 28-6156 is a first-in-class, small molecule for once-daily oral administration, allosteric activator of beta-glucocerebrosidase (GCase), in development for the treatment of pa ...

BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing the novel, selective AXL kinase inhibitor bemcentinib for lung cancer announced today that the first ...